背景:很少有国家级研究评估SARS-CoV-2的Omicron变体的“混合”免疫(疫苗接种和感染恢复)的影响。
方法:从2020年5月到2022年12月,我们进行了系列评估(每个约4000-9000名成年人),检查了来自全国在线投票平台的最具代表性的加拿大队列中的SARS-CoV-2抗体。成人,大多数人都接种了疫苗,报告了病毒检测证实的感染,并将自己收集的干血点邮寄到中央实验室。样品进行了高度敏感和特异性的抗体测定,以刺突和核衣壳蛋白抗原,后者仅由感染引发。我们估计了在Omicron时期之前以及BA.1/1.1和BA.2/5波期间的SARS-CoV-2累积发病率。我们评估了抗体水平和年龄特异性主动免疫水平的变化。
结果:感染者的尖峰水平高于未感染的成年人,无论接种剂量。在至少接种过三次疫苗并在六个月前感染的成年人中,疫苗接种后9个月的峰值水平显著持续下降.相比之下,在六个月内感染的成年人中,穗水平逐渐下降。下降的性别相似,年龄组,和种族。最近的疫苗接种减弱了老年感染的峰值水平下降。在方便示例中,尖峰抗体和细胞反应相关。到2022年底,大约35%的60岁以上的成年人在六个月前接种了最后一次疫苗。约25%未感染。到2022年12月,SARS-CoV-2感染的累积发病率从omicron之前的13%(95%CI11-14%)上升到78%(76-80%),累计相当于2500万感染的成年人。然而,BA.2/5波期间的COVID-19周死亡率不到BA.1/1.1波期间的一半,意味着对混合免疫的保护作用。
结论:维持人群水平的混合免疫的策略需要最新的疫苗接种覆盖率,包括那些从感染中恢复的人。以人口为基础,自采干血斑是一个切实可行的生物监测平台。
资金:资金由COVID-19免疫工作队提供,加拿大卫生研究院,辉瑞全球医疗补助金,和圣迈克尔医院基金会。PJ和ACG由加拿大研究主席计划资助。
Background: Few national-level studies have evaluated the impact of \'hybrid\' immunity (vaccination coupled with recovery from infection) from the Omicron variants of SARS-CoV-2.
Methods: From May 2020 to December 2022, we conducted serial assessments (each of ~4000-9000 adults) examining SARS-CoV-2 antibodies within a mostly representative Canadian cohort drawn from a national online polling platform. Adults, most of whom were vaccinated, reported viral test-confirmed infections and mailed self-collected dried blood spots to a central lab. Samples underwent highly sensitive and specific antibody assays to spike and nucleocapsid protein antigens, the latter triggered only by infection. We estimated cumulative SARS-CoV-2 incidence prior to the Omicron period and during the BA.1/1.1 and BA.2/5 waves. We assessed changes in antibody levels and in age-specific active immunity levels.
Results: Spike levels were higher in infected than in uninfected adults, regardless of vaccination doses. Among adults vaccinated at least thrice and infected more than six months earlier, spike levels fell notably and continuously for the nine months post-vaccination. By contrast, among adults infected within six months, spike levels declined gradually. Declines were similar by sex, age group, and ethnicity. Recent vaccination attenuated declines in spike levels from older infections. In a convenience sample, spike antibody and cellular responses were correlated. Near the end of 2022, about 35% of adults above age 60 had their last vaccine dose more than six months ago, and about 25% remained uninfected. The cumulative incidence of SARS-CoV-2 infection rose from 13% (95% CI 11-14%) before omicron to 78% (76-80%) by December 2022, equating to 25 million infected adults cumulatively. However, the COVID-19 weekly death rate during the BA.2/5 waves was less than half of that during the BA.1/1.1 wave, implying a protective role for hybrid immunity.
Conclusions: Strategies to maintain population-level hybrid immunity require up-to-date vaccination coverage, including among those recovering from infection. Population-based, self-collected dried blood spots are a practicable biological surveillance platform.
Funding: Funding was provided by the COVID-19 Immunity Task Force, Canadian Institutes of Health Research, Pfizer Global Medical Grants, and St. Michael\'s Hospital Foundation. PJ and ACG are funded by the Canada Research Chairs Program.